The Surveillance and Pharmacogenomics Initiative for Adverse Drug Reactions (SAPhIRE) program is actively pursuing additional collaborations in the field of drug safety and is keen to hear from interested individuals in medical, academic and industrial organizations.
Clinical and Academic Centers
Establishing ADRs studies in additional centres
Developing tools for informatics mining of electronic medical records
Investigating populations in other relevantpopulations in South East Asia
Developing pharmacoeconomic models for genomics applications